Cadila Healthcare Q2 PAT seen up 4.8% YoY to Rs. 530 cr: HDFC Securities

HDFC Securities has come out with its second quarter (July-September’ 18) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Cadila Healthcare to report net profit at Rs. 530 crore up 4.8% year-on-year (up 14.5% quarter-on-quarter).

Net Sales are expected to decrease by 5.2 percent Y-o-Y (up 5.9 percent Q-o-Q) to Rs. 3,070 crore, according to HDFC Securities.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 13 percent Y-o-Y (up 15.5 percent Q-o-Q) to Rs. 750 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.